#

EMERGENCY USE

Vaccination Of Children & Adolescents To Be Based On ‘Scientific Rationale’, ‘Supply Situation’: Covid Task Force Chief

CDSCO Expert Panel Recommends Emergency Use Of Covaxin For Children Aged Between 2-18
Decision On WHO Emergency Approval For Covaxin Postponed To Next Week
AIPSN Issues Strong Statement After WHO Denies Covaxin Emergency Use Listing, Presses For Transparency
Pfizer To Get Emergency Use Authorisation For Vaccines In Children Aged 5 to 12 By Oct: Former FDA Chief
Mukesh Ambani’s Reliance Life Sciences Seeks Nod For Covid Vaccine Trial: Report

Bharat Biotech Achieves Another Milestone As Covaxin Receives GMP Certificate From Hungary

About us | Advertisement| Privacy policy

© Copyright@2024.ABP Network Private Limited. All rights reserved.